MatEl introduces a novel, on-chip integration scheme enabling accurate and fast alignment and bonding of any type of chip package on Si3N4, demonstrated in two selected next-gen devices at TRL5:
• Augmented Reality (AR) display featuring a 2D light source for light-field with on-chip RGB lasers and OEIC-based demultiplexer, and
• Bio-photonic sensors for reliable and low-cost detection of Covid-19 featuring integrated on-chip VCSEL at 850 nm and photodetector.
The MatEl consortium has identified an exploitation plan focused on translating these advancements into commercial success, reinforcing collaborations, and enhancing EU industrial capabilities.
Exploitable Results (ERs) have been identified, such as LIFT process and Laser soldering optimisation, assembly and packaging processes of electronic and photonic integrated components, high-quality material development (monolayer graphene, PZT thin films), demonstration of the use of graphene as a photodetector on hybrid biosensor PICs, and in a light-field display technology for AR.
These operate in specific markets. While the materials market, especially for graphene, is still in the R&D phase, it offers significant development opportunities but requires further investment. In contrast, OEIC design, manufacturing, and integration are more mature, and the MatEl project focuses on optimizing these through cost-effective processes. Regarding IP, MatEl partners plan to secure patents, trademarks, know-how, copyrights, and design rights for foreground knowledge developed during the project. IP landscape analysis confirms no third-party IP currently threatens the exploitation of MatEl results or limits partners' Freedom to Operate. Existing consortium-owned patents and partner leadership suggest this will remain stable throughout the project.